(12)
(5)
| 产品: | Endomucin 抗体 |
| 货号: | DF13357 |
| 描述: | Rabbit polyclonal antibody to Endomucin |
| 应用: | WB IF/ICC |
| 文献验证: | IF/ICC |
| 反应: | Human, Mouse, Rat |
| 预测: | Pig, Bovine, Sheep, Rabbit, Dog |
| 蛋白号: | Q9ULC0 |
| RRID: | AB_2846376 |
产品描述
来源:
Rabbit
应用:
IF/ICC 1:100-1:500, WB 1:500-1:2000
*The optimal dilutions should be determined by the end user.
*Tips:
*The optimal dilutions should be determined by the end user.
*Tips:
WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.
反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
Endomucin Antibody detects endogenous levels of total Endomucin.
RRID:
AB_2846376
引用格式: Affinity Biosciences Cat# DF13357, RRID:AB_2846376.
引用格式: Affinity Biosciences Cat# DF13357, RRID:AB_2846376.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:
展开/折叠
EMCN; EMCN2; Endomucin 2; Endomucin; Endomucin-2; Endothelial sialomucin; Gastric cancer antigen Ga34; MUC-14; MUC14; MUCEN_HUMAN; Mucin 14; Mucin-14;
抗原和靶标
免疫原:
A synthesized peptide derived from human Endomucin, corresponding to a region within C-terminal amino acids.
基因/基因ID:
文献引用
1). Conformationally regulated "nanozyme-like" cerium oxide with multiple free radical scavenging activities for osteoimmunology modulation and vascularized osseointegration. Bioactive materials, 2023
(PubMed: 38186961)
[IF=18.9]
Application: IF/ICC Species: human Sample: HUVECs
Fig. 4. Angiogenesis of HUVECs in pattern of DSS and CM, respectively. (A) Crystal violet staining images and (B) counting of the invasive HUVECs on Transwell membrane at 24 h. (C) Scratch images at 0 and 12 h and (D) quantified migration length of HUVECs. (E) Vessel tube formation images of HUVECs along with (F) total capillary length and (H) number of branch points per field at 12 h. (G)Fluorescence staining images and relative intensities of (I) CD31 (red) and (J) Emcn (green) in HUVECs at 5 d *p < 0.05.
2). Biomimetic and spatiotemporally sequential hydrogel delivery system with self-healing and adhesion: Triple growth factor for bone defect repair. Chemical Engineering Journal, 2023
[IF=13.3]
3). Polydatin accelerates osteoporotic bone repair by inducing the osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells via the PI3K/AKT/GSK-3β/β-catenin pathway. International journal of surgery (London, England), 2025
(PubMed: 39248296)
[IF=12.5]
4). Polydatin accelerates osteoporotic bone repair by inducing the osteogenesis-angiogenesis coupling of bone marrow mesenchymal stem cells via the PI3K/AKT/GSK-3β/β-catenin pathway. International journal of surgery (London, England), 2024
(PubMed: 39248296)
[IF=12.5]
Application: IF/ICC Species: Rat Sample:
Figure 7. POL accelerated osteoporotic bone repair by stimulating osteogenesis and angiogenesis via up-regulating β-catenin expression. (A) Images of immunohistochemical staining for VEGFA (scale bar = 200 μm); (B) Quantification of immunohistochemical staining for VEGFA (n = 6); (C) Images of immunohistochemical staining for CD31 (scale bar = 200 μm); (D) Quantification of immunohistochemical staining for CD31 (n = 6); (E) Images of CD31 and EMCN immunofluorescence double-staining (scale bar = 100 μm); (F-H) Quantification of CD31 and EMCN immunofluorescence double-staining (n = 6); (I) Images of immunofluorescence staining for β-catenin (scale bar = 100 μm); (J) Quantification of immunofluorescence staining for β-catenin (n = 6). Data were presented as mean ± SEM. Compared with Sham group: * P < 0.05, **P < 0.01, ***P < 0.001. Compared with OVX + CON group: ### P < 0.001.
5). Chondroitin sulfate/silk fibroin hydrogel incorporating graphene oxide quantum dots with photothermal-effect promotes type H vessel-related wound healing. Carbohydrate polymers, 2024
(PubMed: 38553198)
[IF=10.7]
6). Mesenchymal Stem Cell Aggregation-Released Extracellular Vesicles Induce CD31+ EMCN+ Vessels in Skin Regeneration and Improve Diabetic Wound Healing. Advanced healthcare materials, 2023
(PubMed: 36999744)
[IF=10.0]
7). A vessel subtype beneficial for osteogenesis enhanced by strontium-doped sodium titanate nanorods by modulating macrophage polarization. Journal of Materials Chemistry B, 2020
(PubMed: 32627795)
[IF=6.1]
8). Promoting diabetic oral mucosa wound healing with a light-responsive hydrogel adaptive to the microenvironment. Heliyon, 2024
(PubMed: 39435107)
[IF=4.0]
Application: IF/ICC Species: human Sample:
Fig. 9 IF staining of diabetic oral mucosa defects across various treatment groups. Scale Bar: 200 μm.
9). Effect of M2-macrophage treated lymphatic endothelial cells on angiogenesis that promoted osteointegration. Experimental cell research, 2024
(PubMed: 38768700)
[IF=3.3]
10). Soybean Isoflavones Alleviate Osteoarthritis Through Modulation of the TSC1/mTORC1 Signaling Pathway to Reduce Intrachondral Angiogenesis. Immunological investigations, 2024
(PubMed: 39360672)
[IF=2.9]
限制条款
产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。
产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。
Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。产品仅供科学研究使用。不用于诊断和治疗。
产品未经授权不得转售。
Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.